Modelling the chloroquine chemotherapy of falciparum malaria: The value of spacing a split dose

Parasitology

Volumn 116, Issue 5, 1998, Pages 407-416

  Hoshen, M B ^a   Stein, W D ^a   Ginsburg, H ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Chemotherapy; Chloroquine; Drug resistance; Plasmodium falciparum

Indexed keywords

CHLOROQUINE;

ARTICLE; CHEMOTHERAPY; DOSE RESPONSE; DRUG ELIMINATION; DRUG RECEPTOR BINDING; DRUG RESISTANCE; HUMAN; MALARIA; MATHEMATICAL MODEL; MINIMUM INHIBITORY CONCENTRATION; PARASITEMIA; PHARMACODYNAMICS; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MATHEMATICS; MODELS, BIOLOGICAL; PARASITEMIA; PLASMODIUM FALCIPARUM; PROGNOSIS; TIME FACTORS;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0031897710     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0031182098002480     Document Type: Article

References (27)

1. AL-YAMAN, F., GENTON, B., REEDER, J. C., ANDERS, R. F. & ALPERS, M. P. (1997). Evidence that recurrent Plasmodium falciparum infection is caused by recrudescence of resistant parasites. American Journal of Tropical Medicine and Hygiene 56, 436-439.
2. BRASSEUR, P., AGNAMEY, P., EKOBO, A. S., SAMBA, G., FAVENNEC, L. & KOUAMOUO, J. (1995). Sensitivity of Plasmodium falciparum to amodiaquine and chloroquine in central Africa: a comparative study in vivo and in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 528-530.
3. DURAISINGH, M. T., DRAKELEY, C. J., MULLER, O., BAILEY, R., SNOUNOU, G., TARGETT, G. A. T., GREENWOOD, B. M. & WARHURST, D. C. (1997). Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 4, 205-211.
4. FILIPPOV, A. M. & GLAZUNOVA, Z. I. (1989) [The importance of a quantitative assessment of parasitemia in tropical malaria] (Russian). Medizinskia Parazitologia Moskva 4, 18-21.
5. FOSTER, S. (1994). Economic prospects for a new antimalarial drug. Transactions of the Royal Society of Tropical Medicine and Hygiene 88 (Suppl. 1), S55-S56.
6. GERNAAT, H. B., VERHAGEN, M. A. & WOODS, S. M. (1990). Chloroquine-resistant Plasmodium falciparum malaria at Nchelenge, northeastern Zambia. Follow-up on 515 hospital patients. Tropical and Geographical Medicine 42, 324-329.
7. HELLGREN, U., KINAMIA, C. M., MAHIKWANO, L. F., BJÖRKMAN, A., ERIKSSON, O. & ROMBO, L. (1989). Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine. Bulletin of the World Health Organization 67, 197-202.
8. KARBWANG, J. & HARINASUTA, T. (1992). Overview: clinical pharmacology of antimalarials. Southeast-Asian Journal of Tropical Medicine and Public Health 23 (Suppl. 4), 95-109.
9. KARBWANG, J. & NABANGCHANG, K. (1994). Clinical application of mefloquine pharmacokinetics in the treatment of P. falciparum malaria. Fundamental and Clinical Pharmacology 8, 491-502.
10. KHOROMANA, C. O., CAMPBELL, C. C., WIRIMA, J. J. & HEYMANN, D. L. (1986). In vivo efficacy of chloroquine treatment for Plasmodium falciparum in Malawian children under five years of age. American Journal of Tropical Medicine and Hygiene 35, 465-471.
11. KILIMALI, V. A. E. B. & MKUFYA, A. R. (1985). In vivo and in vitro assessment of the sensitivity of Plasmodium falciparum to chloroquine in four districts of Tanga region, Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 79, 478-481.
12. KRISHNA, S. & WHITE, N. J. (1996). Pharmacokinetics of quinine, chloroquine and amodiaquine: clinical implications. Clinical Pharmacokinetics 30, 263-299.
13. KWIATKOWSKI, D. & NOWAK, M. (1991). Periodic and chaotic host parasite interactions in human malaria. Proceedings of the National Academy of Sciences, USA 88, 5111-5113.
14. LOKMAN-HAKIM, S., SHARIFAH-ROOHI, S. W., ZURKURNAI, Y., NOOR-RAIN, A., MANSOR, S. M., PALMER, K., NAVARATNAM, V. & MAK, J. W. (1996). Plasmodium falciparum: increased proportion of severe resistance (RII and RIII) to chloroquine and high rate of resistance to sulfadoxine-pyrimethamine in Peninsular Malaysia after two decades. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 294-297.
15. MESHNICK, S. R., TAYLOR, T. E. & KAMCHONWONGPAISAN, S. (1996). Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiological Review 60, 301-315.
16. MVONDO, J. L., JAMES, M. A. & CAMPBELL, C. C. (1992) Malaria and pregnancy in Cameroonian women. Effect of pregnancy on Plasmodium falciparum parasitemia and the response to chloroquine. Tropical Medicine and Parasitology 43, 1-5.
17. PUSSARD, E. & VERDIER, F. (1994). Antimalarial 4-aminoquinolines: mode of action and pharmacokinetics. Fundamental and Clinical Pharmacology 8, 1-17.
18. VERDRAGER, J. (1986). Epidemiology and spread of drug-resistant falciparum malaria in Southeast Asia. Southeast-Asian Journal of Tropical Medicine and Public Health 17, 111-118.
19. VERDRAGER, J. (1995). Localized permanent epidemics: the genesis of chloroquine resistance in Plasmodium falciparum. Southeast-Asian Journal of Tropical Medicine and Public Health 26, 23-28.
20. WATKINS, W. M., WINSTANLEY, P. A., MBERU, E. K., KOKWARO, G., MURPHY, S. A., NEWTON, C. J., MWANGI, I., FORSTER, D. & MARSH, K. (1995). Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria. British Journal of Clinical Pharmacology 39, 283-287.
21. WHITE, N. J. (1992). Antimalarial pharmacokinetics and treatment regimens. British Journal of Clinical Pharmacology 34, 1-10.
22. WHITE, N. J. (1995). Optimal regimens of parenteral quinine. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 462-463.
23. WHITE, N. J. (1997). Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrobial Agents and Chemotherapy 41, 1413-1422.
24. WHITE, N. J. & KRISHNA, S. (1989). Treatment of malaria: some considerations and limitations of the current methods of assessment. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 767-777.
25. WINSTANLEY, P. A., MBERU, E. K., WATKINS, W. M., MURPHY, S. A., LOWE, B. & MARSH, K. (1994). Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 577-580.
26. WORLD HEALTH ORGANIZATION (1973). Chemotherapy of malaria. WHO Report Series No. 375.
27. WORLD HEALTH ORGANIZATION (1997). The World Health Report. Conquering, Suffering, Enriching Humanity. WHO Publications, Geneva.